Hyperion Therapeutics Announces First Patient Enrolled In Pivotal Trial In Patients With Urea Cycle Disorders
Links shared publicly online about this topic.
- 1,642total visits
Hyperion Therapeutics Announces First Patient Enrolled In Pivotal Trial In Patients With Urea Cycle Disorders
Hyperion Therapeutics announced that the first patient has been enrolled in its pivotal phase III clinical trial of investigational compound HPN-100 (glycerol phenylbutyrate). The 4-week, multi-ce
View full resource at medicalnewstoday.com
Tags: Disease and Condition, Clinical Trial
Most Recently Shared on October 29, 2009 at 10:33 am By:
Hyperion Therapeutics Announces First Patient Enrolled In Pivotal Trial In Patients With Urea Cycle Disorders: .. http://bit.ly/1vntlq
Hyperion Therapeutics Announces First Patient Enrolled In Trial In Children With Urea Cycle Disorders
medicalnewstoday.com — “Hyperion Therapeutics announced that the first patient has been enrolled in a clinical trial of investigational compound HPN-100 (glycerol phenylbutyrate) in children ages 6-17 with urea cycle dis” View full resource at medicalnewstoday.com
Most Recently Shared on September 17, 2009 at 2:07 pm By:
MNT Pediatrics News Pediatrics and Health News
Hyperion Therapeutics Announces First Patient Enrolled In Trial In Children With Urea Cycle Disorders: Hyperion .. http://bit.ly/3ro3xO
Advertisement
